Literature DB >> 10444241

Prescription-event and other forms of epidemiological monitoring of side-effects in the UK.

N Dunn1, R D Mann.   

Abstract

The post-marketing surveillance (PMS) of drugs is necessary because of the limited size of the clinical safety database at the time of marketing. The principal hypothesis-generating methods of PMS are spontaneous reporting (e.g. the yellow card) and Prescription Event Monitoring. These methods are discussed in this chapter and certain basic pharmacoepidemiological issues that are relevant are briefly reviewed.

Mesh：

Year:  1999        PMID： 10444241     DOI： 10.1046/j.1365-2222.1999.0290s3217.x

Source DB:  PubMed          Journal:  Clin Exp Allergy        ISSN： 0954-7894            Impact factor:   5.018


  7 in total

Review 1.  Call for a new approach to the process of clinical trials and drug registration.

Authors:  T C Jones
Journal:  BMJ       Date:  2001-04-14

2.  Association between SSRIs and upper gastrointestinal bleeding. Coprescription of antiulcer drugs with SSRIs is fairly common.

Authors:  D Williams; A Kelly; J Feely
Journal:  BMJ       Date:  2000-05-20

3.  An information-theoretic approach to surrogate-marker evaluation with failure time endpoints.

Authors:  Assam Pryseley; Abel Tilahun; Ariel Alonso; Geert Molenberghs
Journal:  Lifetime Data Anal       Date:  2010-09-28       Impact factor: 1.588

4.  A call to restructure the drug development process: government over-regulation and non-innovative late stage (Phase III) clinical trials are major obstacles to advances in health care.

Authors:  Thomas C Jones
Journal:  Sci Eng Ethics       Date:  2005-10       Impact factor: 3.525

5.  Adverse Events under Tacrolimus and Cyclosporine in the First 3 Years Post-Renal Transplantation in Children.

Authors:  Pauline Lancia; Beate Aurich; Phuong Ha; Anne Maisin; Véronique Baudouin; Evelyne Jacqz-Aigrain
Journal:  Clin Drug Investig       Date:  2018-02       Impact factor: 2.859

6.  Safety profile of tolterodine as used in general practice in England: results of prescription-event monitoring.

Authors:  D Layton; G L Pearce; S A Shakir
Journal:  Drug Saf       Date:  2001       Impact factor: 5.606

7.  Impact of the black triangle label on prescribing of new drugs in the United Kingdom: lessons for the United States at a time of deregulation.

Authors:  Daniel B Horton; Tobias Gerhard; Amy Davidow; Brian L Strom
Journal:  Pharmacoepidemiol Drug Saf       Date:  2017-08-31       Impact factor: 2.890
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.